BIOPHYTIS announced the promotion of Jean-Christophe Montigny to the position of Chief Operating Officer and the appointment of Daniel Schneiderman as Chief Financial Officer based in the company's U.S. office located in Cambridge, MA. Since 2009, Mr. Jean-Christophe Montigny has been supervising the finance and legal functions of BIOPHYTIS in France. As the newly appointed COO, Mr. Montigny will continue to oversee his previous functions while ensuring cross-functional management alongside Mr. Stanislas Veillet, Chief Executive Officer of the company.

As Chief Financial Officer based in the U.S., Mr. Daniel Schneiderman's roles and responsibilities will include supervising the company's capital markets, investor relations, and certain financial and operational initiatives. He brings over 16 years of capital raising, strategic advisory and operational experience primarily with high-growth companies in the healthcare and life sciences industries. Previously, Mr. Schneiderman served as Vice President of Finance and Controller of MetaStat Inc. Prior to joining MetaStat in 2012, Mr. Schneiderman was Vice President of Investment Banking for Burnham Hill Partners where he worked from 2004.